Skip to main
VEEV

Veeva Systems (VEEV) Stock Forecast & Price Target

Veeva Systems (VEEV) Analyst Ratings

Based on 22 analyst ratings
Buy
Strong Buy 27%
Buy 41%
Hold 27%
Sell 0%
Strong Sell 5%

Bulls say

Veeva Systems is poised for strong growth in the life sciences industry due to its best-of-breed offerings and efficient solutions that displace outdated systems. With a diverse client base and increased demand in the bio-pharma industry, VEEV is well-positioned to maintain competitive advantage and drive revenue growth. Risks may come from larger competitors, but potential aggressive share repurchases and demand for its solutions make VEEV a strong buy.

Bears say

Veeva Systems is facing stiff competition from other companies specializing in healthcare, such as IQVIA (IQV), Definitive Healthcare (DH), and Cognizant (CTSH), which poses a risk to its revenue growth and market share. Additionally, the current macroeconomic environment, including drug pricing reform and a challenged bio-pharma funding environment, may negatively impact demand for Veeva's services. Although the company has a diverse client base and is well-positioned to benefit from the recovery of the bio-pharma industry, it may face challenges in retaining clients and maintaining its pricing strategy. Therefore, the financial analyst has a negative outlook on Veeva System's stock due to potential threats to its revenue growth and profitability.

Veeva Systems (VEEV) has been analyzed by 22 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 41% recommend Buy, 27% suggest Holding, 0% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Veeva Systems and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Veeva Systems (VEEV) Forecast

Analysts have given Veeva Systems (VEEV) a Buy based on their latest research and market trends.

According to 22 analysts, Veeva Systems (VEEV) has a Buy consensus rating as of Jul 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $246.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $246.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Veeva Systems (VEEV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.